norstemizole

诺司咪唑

Report date: 2025/06/26 11:40:14
NME

Base Information

Drug Namenorstemizole
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsAnaphylaxis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBeijing Huashidan Pharmaceutical Technology Co LtdTianjin Angel Power Pharmaceutical Research And Development Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Huashidan Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAnaphylaxis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A